Physician profile
Mark-Friedrich Hurdle
NPI 1952374043
$139,859.99
in general payments reported to CMS, 2019-2025
8 companies · $414 in 2025
The $414 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $8,448 · 2021: $27K · 2022: $25K · 2023: $37K · 2024: $1,558 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $11K · Honoraria: $6,426 · Food and Beverage: $2,612 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,175.00 |
| Travel and Lodging | $10,727.59 |
| Honoraria | $6,426.00 |
| Food and Beverage | $2,612.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $98,380.02 | 2019-2023 | Coolief, Generator |
| Spr Therapeutics, INC | $31,110.49 | 2019-2025 | Sprint Pns System |
| Bioventus LLC | $9,548.02 | 2022-2024 | Stimrouter Implantable Kit, Stimrouter Implantable Kit |
| Bioness INC | $309.92 | 2020 | |
| Stratus Medical, LLC | $173.60 | 2024 | Nimbus |
| Mml US, INC. | $150.45 | 2023 | Reactiv8 |
| Abbott Laboratories | $145.42 | 2023-2024 | Eterna |
| Pacira Pharmaceuticals Incorporated | $42.07 | 2023 | Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark-Friedrich Hurdle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.